Last reviewed · How we verify
blood specimen — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
blood specimen (blood specimen) — Centre Hospitalier Universitaire de Saint Etienne. Blood specimen is a diagnostic sample collection, not a drug with a pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| blood specimen TARGET | blood specimen | Centre Hospitalier Universitaire de Saint Etienne | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- blood specimen CI watch — RSS
- blood specimen CI watch — Atom
- blood specimen CI watch — JSON
- blood specimen alone — RSS
Cite this brief
Drug Landscape (2026). blood specimen — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-specimen. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab